PYQ Vault

ADA deficiency and gene therapy

This type of question, asked 4 times: 2022, 2024, 2025, 2026. All 9 questions below, oldest first.

Try each one first, then open its answer.

  1. Question 1

    2022

    Biotechnology revolves around the "gene of interest", with an objective to open various avenues for human welfare in health, medicine, pharma, agriculture etc. using different techniques, tools and processes. One of the breakthroughs of biotechnology in medicine is the gene therapy.
    13 (b)
    (i) Name the human disease for which the gene therapy was used for the first time. (ii) Explain the steps of gene therapy carried to cure the disease using the lymphocytes of the patient. Why is this therapy not a permanent cure of the disease ? (iii) Write the possible permanent cure of the disease by the gene therapy that is in progress.
  2. Question 2

    2022

    11
    (a) How does a gene therapy involving direct modification of the cells, in order to achieve a therapeutic goal is used in the treatment of ADA deficiency ? Explain. (b) A host cell must be made competent, before it is able to receive an rDNA. Justify.
  3. Question 3

    2024

    Two statements are given, one labelled Assertion (A) and the other labelled Reason (R). Select the correct answer from the options given below.
    16
    Assertion (A) : Functional ADA cDNA genes must be inserted in the lymphocytes at the early embryonic stage in gene therapy for ADA deficiency. Reason (R) : Cells in the embryonic stage are immortal, differentiated and easy to manipulate.

    Tap an option to check your answer.

  4. Question 4

    2024

    24
    The first clinical gene therapy was given in 1990 to a 4-year-old girl with ADA deficiency. (a) Mention the cause of this disorder. (b) List the possible treatments available for this disorder. (c) How can this disorder be cured permanently ?
  5. Question 5

    2024

    18
    Why does a patient of ADA – deficiency require repeated infusions of genetically engineered lymphocytes ? Suggest a possible permanent remedy.
  6. Question 6

    2025

    31 (a)
    (i) Give the full form of 'ELISA'. Write the principle on which ELISA test is based. (ii) Describe all the methods used to treat or cure Adenosine deaminase deficiency in humans.
  7. Question 7

    2025

    21 (A)
    A patient with ADA deficiency requires periodic infusion of genetically engineered lymphocytes. Explain why such periodic infusion is required and also suggest a permanent cure for such ADA deficiency.
  8. Question 8

    2025

    22
    Gene therapy can be used to treat an ADA deficient patient. Explain. Is it a permanent cure ? How can ADA be cured permanently ?
  9. Question 9

    2026

    21
    A child is born with a genetic disorder due to the deletion of a gene. (a) Name such a gene studied by you. Explain how gene therapy can help in treating such a condition. (b) Mention one challenge associated with this therapy.